Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma Academic Article Article uri icon

Overview

MeSH Major

  • Kidney

abstract

  • Progression-free and overall survival with interferon-alpha treatment can be compared with new therapies in phase II and III clinical investigations. The prognostic model is suitable for risk stratification of phase III trials using interferon-alpha as the comparative treatment arm.

publication date

  • January 2002

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1200/JCO.20.1.289

PubMed ID

  • 11773181

Additional Document Info

start page

  • 289

end page

  • 96

volume

  • 20

number

  • 1